Fanny Boursin

Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment–Drug Conjugates (FDCs)

Nicolas Joubert, C. Colas, E. Allard-Vannier, 2022, Pharmaceutics.

An effective strategy for the humanization of antibody fragments under an accelerated timeline.

N. Aubrey, J. Minozzo, P. Billiald, 2022, International journal of biological macromolecules.

Evaluation of immunogenicity and protection of the Mic1-3 knockout Toxoplasma gondii live attenuated strain in the feline host.

C. Su, D. Le Roux, V. Djokic, 2019, Vaccine.

Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential

N. Aubrey, M. Noiray, P. Billiald, 2020, Toxins.

Anticalin N- or C-Terminal on a Monoclonal Antibody Affects Both Production and In Vitro Functionality

G. Ferry, V. Gouilleux-Gruart, G. Thibault, 2022, Antibodies.

Exploration and Modulation of Antibody Fragment Biophysical Properties by Replacing the Framework Region Sequences

M. Pugnière, N. Aubrey, C. Henriquet, 2020, Antibodies.

Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancer.

J. Chezal, Caroline Denevault-Sabourin, Aurélie Maisonial-Besset, 2024, Journal of controlled release : official journal of the Controlled Release Society.